PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsmalignant pleural effusion
MeSH D016066 - malignant pleural effusion
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010997:Pleural neoplasms
0 Companies
0 Drugs
Success rate
D010996:Pleural effusion
53 Companies
3 Drugs
$
Success rate
D016066: 
Malignant pleural effusion
2 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
62%
13/21
Phase 2
29%
7/24
Phase 3
67%
6/9
Approved: 2Overall Success rate: 12%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Recordati
Mechlorethamine
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use